Effects Of Retinoids

Acne No More Ebook

Quick Acne Cure

Get Instant Access

Hypovitaminosis has been related to the expression of acne (25), and so its addition to skin should alleviate the condition. All-trans-RA was the first retinoid used, but it was ineffectual on acne when used systemically. 13-cis-RA (isotretinoin), however, is an extremely effective oral anti-acne drug by causing marked sebosuppression (26). 13-cis-RA has been shown to inhibit significantly sebocyte proliferation, differentiation, and lipid synthesis in vivo. Despite its potent biological effects, 13-cis-RA exhibits only low-binding affinity for CRABP and nuclear receptors (27). This unique antisebotrophic activity results from a selective isomerization to all-trans-RA intracellularly in sebocytes, reduces all-trans-RA inactivation compared with all-trans-RA, and mediates inhibition of sebocyte proliferation (28). The synthesis of CRABP II, which facilitates the degradation of intracellular all-trans-RA, was delayed and induced lesser by 13-cis-RA when compared with all-trans-RA, in vitro. Although all-trans-RA in trace amounts promotes sebocyte growth and differentiation, larger doses induce atrophy of the sebaceous gland and decrease


sebogenesis. In vitro all-frans-RA and selective RAR agonists increase lipid-forming colonies except at higher doses (1026 M), in which only a small number of colonies grew but they were differentiated more greatly. On the other hand, RXR agonists increased the cell growth slightly and lipid-forming colonies dramatically (29-31).

It is important to remember that RA effects in vitro may be completely different to in vivo. Retinoic acid induces sebocyte differentiation in preputial sebocytes, yet in in vivo the opposite occurs. Equally, the effects of RA on the keratinocyte differentiation process are contradictory in vitro and in vivo. Nevertheless, the effects of retinoids on epidermal differentiation will help to improve the acnegen-esis state. Increased levels of epidermal transglutaminase and involucrin are observed together with increases in K6, as would be expected for a proliferating epidermis, but the differentiation in keratin markers (K1 and K10) are not inhibited in vivo. A unique keratin, K13 is also induced in vivo. Filaggrin and loricrin are increased in the longer term (four months) application of RA. As it has been recently reported that reduced Langerhans cell (LC) activity decreases in acne, the increases in LC activity by RA will also be beneficial (32).

The mechanism of action of isotretinoin has however remained elusive, as it does not bind itself to the retinoid receptors. Multiple actions have been proposed from inhibition of sebaceous gland activity, inhibition of the growth of P. acnes, inhibition of inflammation, and improvements in follicular epithelial differentiation. More recently, it has been shown that isotretinoin competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase, resulting in reduced formation of dhihydrotestosterone and thereby reduced sebogenesis (33). Retinoids are reported to increase the expression of transforming growth factor (TGF beta 1-3), and these inhibit keratinocyte proliferation. However, TGF beta-2 and 3, but not TGF beta-1, reduce cell proliferation and lipogenesis in human sebaceous glands in organ culture studies, suggesting that these growth factors may also contribute to the effects of retinoids on sebaceous glands (34 -37).

At present, Accutane (oral 13-cis-RA) is available for the oral treatment of acne, whereas topical treatments include Retin-A (micronized all-frans-RA)— Differin (adapalene or CD271). Retinoic acid cannot be used in cosmetic products but retinol can (Fig. 5) (36). This does have some efficacy, but several new routes are being proposed to enhance its activity by inhibiting esterification and degradation enzymes and also manipulation of HDAC activities (37).

Accq Tag Hplc Traces
FIGURE 5 Typical structures of retinoids. Abbreviation: RA, retinoic acid.


  1. Stern RS. Acne therapy: medication use and sources of care in office-based practice. Arch Dermatol 1996; 132:776 - 780.
  2. Knaggs HE, Wood EJ, Rizer RL, et al. Post-adolescent acne. Int J Cosmet Chem 2004; 26(3):129-138.
  3. Jeremy AH, Holland DB, Roberts SG, et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121(1):20-27.
  4. Macdonald-Hull SM, Cunliffe WJ. Hypovitaminosis A of follicular duct as cause of acne vulgaris. Lancet 1988; 31(2):8626-8627.
  5. Angel P, Szabowski A. Function of AP-1 target genes in mesenchymal-epithelial crosstalk in skin. Biochem Pharmacol 2002; 64(5-6):949-956.
  6. Aranda A, Pascual A. Nuclear hormone receptors & gene expression. Physiol Rev 2001; 81(3):1269-1304.
  7. Mehta K. Retinoids as regulators of gene transcription. J Biol Regul Homeost Agents 2003; 17:1-12.
  8. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996; 10:1002-1013.
  9. Rastinejad F. Retinoid X receptor and its partners in the nuclear receptor family. Curr Opin Struct Biol 2001; 11:33-38.
  10. Ahuja HS, Szanto A, Nagy L, et al. The retinoid X receptor & its ligands: versatile regulators of metabolic function, cell differentiation & cell death. J Biol Regul Homeost Agents 2003; 17(1):29 -45.
  11. Wurtz JM, Bourguet W, Renaud JP, et al. A canonical structure for the ligand binding domain of nuclear receptors. Nat Struct Biol 1996; 3:87-94.
  12. Gampe RT, Montana VG, Lambert MH, et al. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell 2000; 5:545-555.
  13. Egea PF, Mitschler A, Rochel N, et al. Crystal structure of the human RXRalpha ligand binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J 2000; 19:2592-2601.
  14. Bourguet W, Vivat V, Wurtz JM, et al. Crystal structure of a heterodimeric complex of RAR & RXR ligand-binding domains. Mol Cell 2000; 5:289-298.
  15. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 2004; 53:1003-1009.
  16. Jung M. Inhibitors of histone deacetylase as new anticancer agents. Curr Med Chem 2002; 8(12):1505-1511.
  17. Roos TC, Jugert FK, Merk HF, et al. Retinoid metabolism in the skin. Pharmacol Rev 1998; 50(2):315-333.
  18. Napoli JL. Interactions of retinoid binding proteins & enzymes in retinoid metabolism. BBA 1999; 1440:139-162.
  19. Kurlandsky SB, Duell EA, Kang S, et al. Autoregulation of retinoic acid biosynthesis through regulation of retinol esterification in human keratinocytes. J Biol Chem 1996; 271(26):15346-15352.
  20. Duell EA, Kang S, Voorhees JJ. Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid. J Invest Dermatol 1996; 106(2):316-320.
  21. Mirikar Y, Wang Z, Duell EA, et al. Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratino-cyte HaCaT cells. J Invest Dermatol 1998; 111(3):434-439.
  22. Kang S, Duell EA, Kim KJ, et al. Liarozole in hibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. J Invest Dermatol 1996; 107:183-187.
  23. Iobst S, Feinberg C, Rawlings AV, et al. Manipulation of retinoid metabolism. J Invest Dermatol 2003; 121:0563.
  24. Granger S, Rawlings AV, Scott IR. Compositions to mimic retinoic acid. European Patent WO9813020.
  25. Wolbach SB, Howe PR. Tissue changes following deprivation of fat soluble A vitamin. J Exp Med 1925; 42:753 - 777.
  26. Goldstein JS, Socha-Szott A, Thomsen RJ, et al. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. J Am Acad Dermatol 1982; 6:760-765.
  27. Downie MMT, Guy R, Kealey T. Advances in sebaceous gland research: potential new approaches to acne management. Int J Cosmet Chem 2004; 26(6):291-312.
  28. Tsukada M, Schroder M, Roos TC, et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid receptors. J Invest Dermatol 2000; 115:321-327.
  29. Zouboulis CC, Korge B, Akamatsu H, et al. Effects of 13-cis Retnoic acid, all trans retinoic acid and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol 1991; 96:792-797.
  30. Zouboulis CC, Korge B, Mischke D, et al. Altered proliferation, synthetic activity & differentiation of cultured human sebocytes in the absence of vitamin A and their modulation by synthetic retinoids. J Invest Dermatol 1993; 101:628-633.
  31. Kim MJ, Ciletti N, Michael S, et al. The role of specific retinoid receptors in sebocyte growth & differentiation in culture. J Invest Dermatol 2000; 114:349-353.
  32. Griffiths CEM, Voorhees JJ. Human in vivo pharmacology of topical retinoids. Arch Dermatol Res 1994; 287:53-60.
  33. Glick AB, McCune BK, Abdulkarem N, et al. Complex regulation of TGFbeta expression by retinoic acid in the vitamin A deficient rat. Development 1991; 111:1081-1086.
  34. Fisher GJ, Tavakkol A, Griffiths CEM, et al. Differential modulation of TGFbeta expression & mucin deposition by retinoic acid & SLS in human skin. J Invest Dermatol 1992; 98:102-108.
  35. Han GR, Dohi DF, Lee HY, et al. All trans retinoic acid increases TGFbeta2 & IGFBP-3 expression through a retinoic acid receptor alpha dependent signalling pathway. J Biol Chem 1997; 272:13711-13716.
  36. Dawson MI. Synthetic retinoids & their nuclear receptors. Curr Med Chem 2004; 4:199-230.
  37. Schehlmann V, Klock J, Maillan P, Vollhardt J, Rawlings AV, Beumer R. Composition comprising an HDAC inhibitor in combination with a retinoid. European Patent WO2005092283, 2005.

Was this article helpful?

0 0
Solve Your Acne Problems

Solve Your Acne Problems

Solve Your Acne Problems With These Simple Home Remedies.

Get My Free Ebook

Post a comment